These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23953376)

  • 1. TRILOGY ACS: prasugrel of benefit only after angiography?
    Swaminathan RV; Feldman DN
    Lancet; 2013 Aug; 382(9892):580-2. PubMed ID: 23953376
    [No Abstract]   [Full Text] [Related]  

  • 2. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial.
    Wiviott SD; White HD; Ohman EM; Fox KA; Armstrong PW; Prabhakaran D; Hafley G; Lokhnygina Y; Boden WE; Hamm C; Clemmensen P; Nicolau JC; Menozzi A; Ruzyllo W; Widimsky P; Oto A; Leiva-Pons J; Pavlides G; Winters KJ; Roe MT; Bhatt DL
    Lancet; 2013 Aug; 382(9892):605-13. PubMed ID: 23953385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy.
    Gurbel PA; Erlinge D; Ohman EM; Neely B; Neely M; Goodman SG; Huber K; Chan MY; Cornel JH; Brown E; Zhou C; Jakubowski JA; White HD; Fox KA; Prabhakaran D; Armstrong PW; Tantry US; Roe MT;
    JAMA; 2012 Nov; 308(17):1785-94. PubMed ID: 23117779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.
    Chin CT; Roe MT; Fox KA; Prabhakaran D; Marshall DA; Petitjean H; Lokhnygina Y; Brown E; Armstrong PW; White HD; Ohman EM;
    Am Heart J; 2010 Jul; 160(1):16-22.e1. PubMed ID: 20598967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prasugrel versus clopidogrel for acute coronary syndromes.
    Lynch DR; Dantzler DM; Zhao D
    N Engl J Med; 2013 Jan; 368(2):188. PubMed ID: 23301742
    [No Abstract]   [Full Text] [Related]  

  • 6. Prasugrel versus clopidogrel for acute coronary syndromes.
    Roe MT; Ohman EM;
    N Engl J Med; 2013 Jan; 368(2):188-9. PubMed ID: 23301741
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: an analysis from the TRITON-TIMI 38 trial.
    De Servi S; Goedicke J; Schirmer A; Widimsky P
    Eur Heart J Acute Cardiovasc Care; 2014 Dec; 3(4):363-72. PubMed ID: 24818952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.
    Roe MT; Armstrong PW; Fox KA; White HD; Prabhakaran D; Goodman SG; Cornel JH; Bhatt DL; Clemmensen P; Martinez F; Ardissino D; Nicolau JC; Boden WE; Gurbel PA; Ruzyllo W; Dalby AJ; McGuire DK; Leiva-Pons JL; Parkhomenko A; Gottlieb S; Topacio GO; Hamm C; Pavlides G; Goudev AR; Oto A; Tseng CD; Merkely B; Gasparovic V; Corbalan R; Cinteză M; McLendon RC; Winters KJ; Brown EB; Lokhnygina Y; Aylward PE; Huber K; Hochman JS; Ohman EM;
    N Engl J Med; 2012 Oct; 367(14):1297-309. PubMed ID: 22920930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prasugrel STEMI subgroup analysis.
    Shil AB; Strohm MP
    Lancet; 2009 May; 373(9678):1846; author reply 1846-8. PubMed ID: 19482212
    [No Abstract]   [Full Text] [Related]  

  • 10. [What kind of antiplatelet treatment in acute coronary syndrome?--Intensive antiplatelet treatment only for patients with invasive strategy].
    Meinertz T
    Dtsch Med Wochenschr; 2013 Nov; 138(45):2288. PubMed ID: 24163163
    [No Abstract]   [Full Text] [Related]  

  • 11. Prasugrel STEMI subgroup analysis.
    Floyd J; Wolfe S
    Lancet; 2009 May; 373(9678):1845-6; author reply 1846-8. PubMed ID: 19482209
    [No Abstract]   [Full Text] [Related]  

  • 12. Prasugrel STEMI subgroup analysis.
    Webster MW; Gladding P
    Lancet; 2009 May; 373(9678):1846; author reply 1846-8. PubMed ID: 19482210
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiplatelet agents make a comeback in ST-elevation myocardial infarction.
    Wiviott SD; de Lemos JA
    Am Heart J; 2007 Oct; 154(4):603-6. PubMed ID: 17892976
    [No Abstract]   [Full Text] [Related]  

  • 14. Prasugrel versus clopidogrel.
    von Lewinski F; Riggert J; Paulus W
    N Engl J Med; 2008 Mar; 358(12):1299; author reply 1299-301. PubMed ID: 18357639
    [No Abstract]   [Full Text] [Related]  

  • 15. [Platelet inhibition with prasugrel].
    Gassanov N; Caglayan E; Nia AM; Erdmann E; Er F
    Dtsch Med Wochenschr; 2010 Aug; 135(31-32):1542-6. PubMed ID: 20665417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prasugrel versus clopidogrel.
    Serebruany V
    N Engl J Med; 2008 Mar; 358(12):1298; author reply 1299-301. PubMed ID: 18354110
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter by Serebruany regarding article, "Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38".
    Serebruany VL
    Circulation; 2010 Aug; 122(8):e436; author reply e437. PubMed ID: 20733108
    [No Abstract]   [Full Text] [Related]  

  • 18. Reanalysis or redefinition of the hypothesis?
    Ciolino JD; Carter RE
    Eur Heart J; 2015 Feb; 36(6):340-1. PubMed ID: 25139897
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute coronary syndromes and coronary intervention.
    Lüscher TF
    Eur Heart J; 2015 Feb; 36(6):323-4. PubMed ID: 25660518
    [No Abstract]   [Full Text] [Related]  

  • 20. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
    Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.